33143372|t|Age-Dependent and Sleep/Seizure-Induced Pathomechanisms of Autosomal Dominant Sleep-Related Hypermotor Epilepsy.
33143372|a|The loss-of-function S284L-mutant alpha4 subunit of the nicotinic acetylcholine receptor (nAChR) is considered to contribute to the pathomechanism of autosomal dominant sleep-related hypermotor epilepsy (ADSHE); however, the age-dependent and sleep-related pathomechanisms of ADSHE remain to be clarified. To explore the age-dependent and sleep-induced pathomechanism of ADSHE, the present study determined the glutamatergic transmission abnormalities associated with alpha4beta2-nAChR and the astroglial hemichannel in the hyperdirect and corticostriatal pathways of ADSHE model transgenic rats (S286L-TG) bearing the rat S286L-mutant Chrna4 gene corresponding to the human S284L-mutant CHRNA4 gene of ADSHE, using multiprobe microdialysis and capillary immunoblotting analyses. This study could not detect glutamatergic transmission in the corticostriatal pathway from the orbitofrontal cortex (OFC) to the striatum. Before ADSHE onset (four weeks of age), functional abnormalities of glutamatergic transmission compared to the wild-type in the cortical hyperdirect pathway, from OFC to the subthalamic nucleus (STN) in S286L-TG, could not be detected. Conversely, after ADSHE onset (eight weeks of age), glutamatergic transmission in the hyperdirect pathway of S286L-TG was enhanced compared to the wild-type. Notably, enhanced glutamatergic transmission of S286L-TG was revealed by hemichannel activation in the OFC. Expression of connexin43 (Cx43) in the OFC of S286L-TG was upregulated after ADSHE onset but was almost equal to the wild-type prior to ADSHE onset. Differences in the expression of phosphorylated protein kinase B (pAkt) before ADSHE onset between the wild-type and S286L-TG were not observed; however, after ADSHE onset, pAkt was upregulated in S286L-TG. Conversely, the expression of phosphorylated extracellular signal-regulated kinase (pErk) was already upregulated before ADSHE onset compared to the wild-type. Both before and after ADSHE onset, subchronic nicotine administration decreased and did not affect the both expression of Cx43 and pErk of respective wild-type and S286L-TG, whereas the pAkt expression of both the wild-type and S286L-TG was increased by nicotine. Cx43 expression in the plasma membrane of the primary cultured astrocytes of the wild-type was increased by elevation of the extracellular K+ level (higher than 10 mM), and the increase in Cx43 expression in the plasma membrane required pErk functions. These observations indicate that a combination of functional abnormalities, GABAergic disinhibition, and upregulated pErk induced by the loss-of-function S286L-mutant alpha4beta2-nAChR contribute to the age-dependent and sleep-induced pathomechanism of ADSHE via the upregulation/hyperactivation of the Cx43 hemichannels.
33143372	24	31	Seizure	Disease	MESH:D012640
33143372	59	111	Autosomal Dominant Sleep-Related Hypermotor Epilepsy	Disease	MESH:D020183
33143372	134	139	S284L	ProteinMutation	tmVar:p|SUB|S|284|L;HGVS:p.S284L;VariantGroup:0;OriginalGene:25590;CorrespondingGene:1137;RS#:28931591;CorrespondingSpecies:10116;CA#:313555
33143372	203	208	nAChR	Gene	1137
33143372	263	315	autosomal dominant sleep-related hypermotor epilepsy	Disease	MESH:D020183
33143372	317	322	ADSHE	Disease	MESH:D020183
33143372	389	394	ADSHE	Disease	MESH:D020183
33143372	484	489	ADSHE	Disease	MESH:D020183
33143372	681	686	ADSHE	Disease	MESH:D020183
33143372	704	708	rats	Species	10116
33143372	710	715	S286L	ProteinMutation	tmVar:p|SUB|S|286|L;HGVS:p.S286L;VariantGroup:1;OriginalGene:25590;CorrespondingGene:1137;CorrespondingSpecies:10116
33143372	732	735	rat	Species	10116
33143372	736	741	S286L	ProteinMutation	tmVar:p|SUB|S|286|L;HGVS:p.S286L;VariantGroup:1;OriginalGene:25590;CorrespondingGene:1137;CorrespondingSpecies:10116
33143372	749	755	Chrna4	Gene	25590
33143372	782	787	human	Species	9606
33143372	788	793	S284L	ProteinMutation	tmVar:p|SUB|S|284|L;HGVS:p.S284L;VariantGroup:0;OriginalGene:25590;CorrespondingGene:1137;RS#:28931591;CorrespondingSpecies:10116;CA#:313555
33143372	801	807	CHRNA4	Gene	1137
33143372	816	821	ADSHE	Disease	MESH:D020183
33143372	1039	1044	ADSHE	Disease	MESH:D020183
33143372	1235	1240	S286L	ProteinMutation	tmVar:p|SUB|S|286|L;HGVS:p.S286L;VariantGroup:1;OriginalGene:25590;CorrespondingGene:1137;CorrespondingSpecies:10116
33143372	1286	1291	ADSHE	Disease	MESH:D020183
33143372	1377	1382	S286L	ProteinMutation	tmVar:p|SUB|S|286|L;HGVS:p.S286L;VariantGroup:1;OriginalGene:25590;CorrespondingGene:1137;CorrespondingSpecies:10116
33143372	1474	1479	S286L	ProteinMutation	tmVar:p|SUB|S|286|L;HGVS:p.S286L;VariantGroup:1;OriginalGene:25590;CorrespondingGene:1137;CorrespondingSpecies:10116
33143372	1548	1558	connexin43	Gene	24392
33143372	1560	1564	Cx43	Gene	24392
33143372	1580	1585	S286L	ProteinMutation	tmVar:p|SUB|S|286|L;HGVS:p.S286L;VariantGroup:1;OriginalGene:25590;CorrespondingGene:1137;CorrespondingSpecies:10116
33143372	1611	1616	ADSHE	Disease	MESH:D020183
33143372	1670	1675	ADSHE	Disease	MESH:D020183
33143372	1762	1767	ADSHE	Disease	MESH:D020183
33143372	1800	1805	S286L	ProteinMutation	tmVar:p|SUB|S|286|L;HGVS:p.S286L;VariantGroup:1;OriginalGene:25590;CorrespondingGene:1137;CorrespondingSpecies:10116
33143372	1843	1848	ADSHE	Disease	MESH:D020183
33143372	1880	1885	S286L	ProteinMutation	tmVar:p|SUB|S|286|L;HGVS:p.S286L;VariantGroup:1;OriginalGene:25590;CorrespondingGene:1137;CorrespondingSpecies:10116
33143372	2011	2016	ADSHE	Disease	MESH:D020183
33143372	2072	2077	ADSHE	Disease	MESH:D020183
33143372	2096	2104	nicotine	Chemical	MESH:D009538
33143372	2172	2176	Cx43	Gene	24392
33143372	2214	2219	S286L	ProteinMutation	tmVar:p|SUB|S|286|L;HGVS:p.S286L;VariantGroup:1;OriginalGene:25590;CorrespondingGene:1137;CorrespondingSpecies:10116
33143372	2278	2283	S286L	ProteinMutation	tmVar:p|SUB|S|286|L;HGVS:p.S286L;VariantGroup:1;OriginalGene:25590;CorrespondingGene:1137;CorrespondingSpecies:10116
33143372	2304	2312	nicotine	Chemical	MESH:D009538
33143372	2314	2318	Cx43	Gene	24392
33143372	2503	2507	Cx43	Gene	24392
33143372	2721	2726	S286L	ProteinMutation	tmVar:p|SUB|S|286|L;HGVS:p.S286L;VariantGroup:1;OriginalGene:25590;CorrespondingGene:1137;CorrespondingSpecies:10116
33143372	2820	2825	ADSHE	Disease	MESH:D020183
33143372	2870	2874	Cx43	Gene	24392
33143372	Association	MESH:D020183	RS#:28931591;HGVS:p.S284L;CorrespondingGene:1137
33143372	Association	MESH:D020183	HGVS:p.S286L;CorrespondingGene:1137
33143372	Association	MESH:D009538	RS#:28931591;HGVS:p.S284L;CorrespondingGene:1137
33143372	Association	MESH:D020183	25590
33143372	Association	MESH:D009538	HGVS:p.S286L;CorrespondingGene:1137
33143372	Association	MESH:D020183	1137
33143372	Association	MESH:D009538	MESH:D020183
33143372	Association	MESH:D020183	1137

